Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-16-009575

Director bought 300,000 shares at $2.35 ($705,000)

From the SEC's structured data for this filing

Trades in this filing

BROADWOOD PARTNERS LP · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-01-20 Purchase : show line 1 in the form +300,000 $2.35 $705,000 22,164,396 D
2016-01-20 Purchase : show line 2 in the form +0 22,164,396 I
Open-market purchases · 300,000 sh · avg $2.35 · $705,000
Loading xslF345X03/p7011950.xml…